The whole transcriptome analysis and the circRNA-lncRNA network construction in arsenic trioxide-treated mice myocardium.
暂无分享,去创建一个
Baofeng Yang | Juan Xu | Yunlong Bai | Xia Li | Chaorun Dong | Yang Gao | Yanan Jiang | Fengnan Zhi | C. Shi | Xiuyun Shen | D. Shang | Jincheng Xu | Yuqiu Chao
[1] Tao Yang,et al. LuQi Formula Regulates NLRP3 Inflammasome to Relieve Myocardial-Infarction-Induced Cardiac Remodeling in Mice , 2021, Evidence-based complementary and alternative medicine : eCAM.
[2] Yanjie Lu,et al. The long noncoding RNA lncCIRBIL disrupts the nuclear translocation of Bclaf1 alleviating cardiac ischemia–reperfusion injury , 2021, Nature communications.
[3] Wenliang Song,et al. Inhibition of micro RNA miR-122-5p prevents lipopolysaccharide-induced myocardial injury by inhibiting oxidative stress, inflammation and apoptosis via targeting GIT1 , 2021, Bioengineered.
[4] Burton B. Yang,et al. YAP Circular RNA, circYap, Attenuates Cardiac Fibrosis via Binding with Tropomyosin-4 and Gamma-Actin Decreasing Actin Polymerization , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.
[5] A. Dinda,et al. Activation of toll like receptor 4 (TLR4) promotes cardiomyocyte apoptosis through SIRT2 dependent p53 deacetylation , 2020, Scientific Reports.
[6] Yonggang Cao,et al. Inhibition of lncRNA Gm15834 attenuates autophagy-mediated myocardial hypertrophy via miR-30b-3p/ULK1 axis in mice. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.
[7] G. Goodall,et al. RNA in cancer , 2020, Nature reviews. Cancer.
[8] R. Malhotra,et al. The molecular mechanism involved in cardioprotection by the dietary flavonoid fisetin as an agonist of PPAR-γ in a murine model of myocardial infarction. , 2020, Archives of biochemistry and biophysics.
[9] Baofeng Yang,et al. Ranolazine protects against diabetic cardiomyopathy by activating the NOTCH1/NRG1 pathway. , 2020, Life sciences.
[10] M. Voso,et al. When Poisons Cure: The Case of Arsenic in Acute Promyelocytic Leukemia , 2020, Chemotherapy.
[11] E. Gao,et al. TXNIP/Redd1 Signaling and Excessive Autophagy: A Novel Mechanism of Myocardial Ischemia/Reperfusion Injury in Mice. , 2020, Cardiovascular research.
[12] Yunlong Bai,et al. Downregulation of miR-200a protects cardiomyocyte against apoptosis. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[13] Yuxuan Luo,et al. lncRNA XIST attenuates hypoxia-induced H9c2 cardiomyocyte injury by targeting the miR-122-5p/FOXP2 axis. , 2019, Molecular and cellular probes.
[14] Zhiwei Wang,et al. miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice , 2019, Oxidative medicine and cellular longevity.
[15] L. Lv,et al. Arsenic trioxide inhibits EMT in hepatocellular carcinoma by promoting lncRNA MEG3 via PKM2. , 2019, Biochemical and biophysical research communications.
[16] Yingbin Xiao,et al. Sirt1 promotes autophagy and inhibits apoptosis to protect cardiomyocytes from hypoxic stress , 2019, International journal of molecular medicine.
[17] Jinyong Peng,et al. Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress , 2018, Redox biology.
[18] Zhiguo Wang,et al. Downregulation of Long Non-Coding RNA Kcnq1ot1: An Important Mechanism of Arsenic Trioxide-Induced Long QT Syndrome , 2018, Cellular Physiology and Biochemistry.
[19] R. Bohle,et al. MiR-34a-3p alters proliferation and apoptosis of meningioma cells in vitro and is directly targeting SMAD4, FRAT1 and BCL2 , 2017, Aging.
[20] D. Bartel,et al. Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.
[21] K. Alimoghaddam,et al. Arsenic trioxide Alters the MicroRNA Expression Profile of U87 glioblastoma. , 2015, Anti-cancer agents in medicinal chemistry.
[22] Petar Glažar,et al. circBase: a database for circular RNAs , 2014, RNA.
[23] P. Pandolfi,et al. The multilayered complexity of ceRNA crosstalk and competition , 2014, Nature.
[24] X. Chen,et al. Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling. , 2013, International journal of cardiology.
[25] C. Elmets,et al. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein. , 2013, Biochemical and biophysical research communications.
[26] Yi Zhao,et al. Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts , 2013, Nucleic acids research.
[27] Sebastian D. Mackowiak,et al. Circular RNAs are a large class of animal RNAs with regulatory potency , 2013, Nature.
[28] Shanfa Lu,et al. High-Throughput Sequencing and Characterization of the Small RNA Transcriptome Reveal Features of Novel and Conserved MicroRNAs in Panax ginseng , 2012, PloS one.
[29] Jiabei Wang,et al. microRNA expression alteration after arsenic trioxide treatment in HepG‐2 cells , 2011, Journal of gastroenterology and hepatology.
[30] Michael Kohl,et al. Cytoscape: software for visualization and analysis of biological networks. , 2011, Methods in molecular biology.
[31] Anjali J. Koppal,et al. Supplementary data: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites , 2010 .
[32] S. Xue,et al. Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning , 2009, Heart and Vessels.
[33] Yoshihiro Yamanishi,et al. KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..
[34] Yong Zhang,et al. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine , 2007, Nucleic Acids Res..
[35] Chih-Hung Hsu,et al. Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial , 2006, Investigational New Drugs.
[36] Jan Krüger,et al. RNAhybrid: microRNA target prediction easy, fast and flexible , 2006, Nucleic Acids Res..
[37] S. Soignet,et al. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. , 2001, Annals of internal medicine.
[38] S. Soignet,et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[40] R Aikawa,et al. MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes. , 1999, Circulation.
[41] C. Niu,et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. , 1997, Blood.
[42] Wei Tang,et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. , 1997, Blood.